News
GRFS
8.60
-1.04%
-0.09
BRIEF-Grifols Receives FDA Approval For Its Malaria Blood Screening Assay
Reuters · 20h ago
Grifols wins FDA approval for Procleix Plasmodium malaria blood screening assay
PUBT · 20h ago
Biotest AG renames as Biotest GmbH & Co. KGaA after legal form change
PUBT · 21h ago
Biotest completes legal form change to partnership limited by shares
PUBT · 21h ago
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
TipRanks · 2d ago
Grifols refinances 2027 maturities with €3.1 billion Term Loan B, $2.1 billion revolver
PUBT · 2d ago
Weekly Report: what happened at GRFS last week (0406-0410)?
Weekly Report · 3d ago
Grifols plans to redeem EUR 500 million of 7.5% senior secured notes due 2030
PUBT · 4d ago
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 04/09 12:08
Weekly Report: what happened at GRFS last week (0330-0403)?
Weekly Report · 04/06 10:35
Grifols facing restrictions in Canada after plasma donor deaths
Seeking Alpha · 04/02 16:39
'Grifols' Canadian License Restricted After Plasma Donor Deaths' - Bloomberg
Benzinga · 04/02 15:46
New conditions imposed on Grifols by Health Canada, CBC News reports
TipRanks · 04/02 15:35
Grifols refinances 2027 maturities with upsized EUR 3 billion term loan B
Reuters · 04/01 18:09
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade)
Seeking Alpha · 03/30 13:17
Weekly Report: what happened at GRFS last week (0323-0327)?
Weekly Report · 03/30 10:35
Grifols rallies after board approves IPO of U.S. Biopharma business
TipRanks · 03/25 09:10
Biggest stock movers Wednesday: ARM, KBH, and more
Seeking Alpha · 03/25 09:01
Grifols Plans IPO of U.S. Biopharma Business
Dow Jones · 03/25 07:53
Grifols considers IPO of part of its US biopharma business
Seeking Alpha · 03/24 21:40
More
Webull provides a variety of real-time GRFS stock news. You can receive the latest news about Grifols S A through multiple platforms. This information may help you make smarter investment decisions.
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.